
1. Technology overview
Nucleo Research is a Y Combinator Fall 2025 company based in San Francisco, listed by YC in the Healthcare category. It targets the delay between cancer diagnosis and treatment start, which the company attributes partly to manual image-analysis steps in the oncology workflow.
A clinician imports a CT scan and the software extracts oncology metrics automatically, including body composition and sarcopenia, tumor lesion volume and target versus non-target lesion classification. The company's site states that it works with hospitals in the US and worldwide.
2. Highlighted features & specifications
- CT import: clinicians load a CT scan into the software for automatic analysis.
- Body composition: automatic detection and quantification of fat and muscle mass for sarcopenia assessment.
- Tumor lesion sizing: precise and consistent measurement of tumor lesions in CT scans.
- Lesion classification: automated target versus non-target lesion classification following RECIST criteria.
- Demo access: hospitals and partners can book a demo through the site.
3. Potential application
Cancer hospitals could use it to standardize tumor response measurement on follow-up CT scans. Clinical trial sites could apply it to consistent lesion sizing. Nutrition and surgical teams could use sarcopenia metrics to assess patient fitness for treatment.
4. Benefits
Segmentation is reported as 2,500 times faster than manual work. Validation studies cited by the company report 98% agreement with medical experts. Consistent lesion measurement reduces variability between readers. Automated metrics are intended to shorten the interval before treatment starts.
5. Market trends & opportunities
Cancer imaging volumes keep growing while radiology and oncology staff are limited, which raises demand for automated measurement. Hospitals in Vietnam and Southeast Asia face similar reading backlogs at cancer centers, so CT analysis tools are of growing interest.
6. Other information
Y Combinator Fall 2025 batch; San Francisco per YC listing. The site footer shows Nucleo Research 2026. Founding year and legal entity are not stated on the fetched pages.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































